Shanghai Ddsome Laboratories Co., Ltd announced that it will issue common shares for the gross proceeds of CNY 28,000,000 on April 16, 2023. The transaction will include particpation from returning investor Zhejiang Starry Pharmaceutical Co.,Ltd. wherein CNY 305,218 will go to registered capital. Before the capital increase, investor has registered capital of CNY 434,783 with 6.4125% stake and post capital increase the registered capital is CNY 740,001 with 10.4440% stake.

The transaction has been approved in the 30th Meeting of the Company’s 4th Directorate and the 20th Meeting of the 4th Supervisory Board held on April 16, 2023, and does not need the Shareholders’ Approval.